USPTO serial 79420419
PLURI
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 1, 2026
- Examiner
- STEINPFAD, SARAH E
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with PLURI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Roy D. Gross
Roy D. Gross The Roy Gross Law Firm, LLC19 Old Kings Hwy S, Suite 200Darien, CT 06820United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological preparations for use in industry and science; bioengineered cells for use in industry and science; bioengineered human T cells for use in industry and science; human and animal cells from placentas for use in industry and science; human and animal cells from placentas for use in the manufacture of cosmetic and aesthetic products; human and animal cells from placentas for use in the manufacture of biological preparations for prevention of hair loss; isolated plant cells for use in industry and science; isolated and cultivated adherent cells from placenta tissue for use industry and science; isolated and cultivated adherent stromal cells derived from placentas of multiple donors for use in industry and science; isolated and cultivated mammal cells for use in industrial manufacture of foodstuff; isolated and cultivated fish cells and/or sea food animal cells for use in industrial manufacture of foodstuff; isolated and cultivated plant cells for use in industrial manufacture of foodstuff. | ACTIVE | — |
| 005 | Cells for medical and clinical use and biological preparations for use in cell cultures for medical purposes; bioengineered cells and bioengineered biological tissue for medical and clinical use; bioengineered cells for use in immunotherapies for cancer and other diseases; bioengineered human T cells for medical and clinical use; human and animal cells from placentas for medical and clinical use; dietary supplements based on human and animal cells from placentas for cosmetic and aesthetic use; dietary supplements and medical preparations based on human and animal cells from placentas for use in prevention of hair loss; isolated plant cells for medical and clinical use; isolated and cultivated adherent cells from placenta tissue for medical and clinical use; isolated and cultivated adherent stromal cells derived from placentas of multiple donors for medical and clinical use; isolated and cultivated plant cells, for medical and clinical use and pharmaceutical preparations containing the same | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific research in the field of isolation and culturing of animal cells and plant cells and animal and plant tissues isolation and culturing, biological preparations intended for medical, clinical, and scientific use of cultured cells and their extracts, bioengineered cells and tissues, bioengineered cells for use in immunotherapy for cancer and other diseases, bioengineered human T cells, isolated and cultivated human and animal placentas cells, isolated plant cells and their extracts, isolated and cultivated adherent cells from placenta tissue, isolated and cultivated adherent stromal cells derived from placentas of multiple donors, isolated and cultivated mammal cells, their extracts and preparations containing them, isolated and cultivated fish cells and sea food cells and preparations containing the same, isolated and cultivated plant cells and their extracts and preparations containing the same; scientific research, development and testing services in the fields of mass production of animal and plant cells for pharmaceuticals; scientific research, development and testing services in the fields of large scale production of various cells in bioreactors for pharmaceuticals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PLURI BIOTECH LTD
- Other trademarks owned by PLURI BIOTECH LTD
- Other trademarks owned by PLURI BIOTECH LTD
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named PLURI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 17, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 2, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 2, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 1, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 1, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 14, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 14, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 8, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 16, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 9, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 9, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 9, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 12, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 20, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 20, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 27, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 26, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 24, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 23, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 23, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 3, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |